KJIM :: Korean Journal of Internal Medicine

Effects of Shenling Baizhu Powder on Intestinal Short-Chain Fatty Acid Content and Intestinal Protection in Rats with Inflammatory Bowel Disease

Advances in Clinical Medicine.2024; 14(03): 1930. CrossRef

Progress in hospital-home transitional care for patients with inflammatory bowel disease

World Chinese Journal of Digestology.2024; 32(3): 208. CrossRef

Artificial intelligence and inflammatory bowel disease: Where are we going?

Leonardo Da Rio, Marco Spadaccini, Tommaso Lorenzo Parigi, Roberto Gabbiadini, Arianna Dal Buono, Anita Busacca, Roberta Maselli, Alessandro Fugazza, Matteo Colombo, Silvia Carrara, Gianluca Franchellucci, Ludovico Alfarone, Antonio Facciorusso, Cesare Ha

World Journal of Gastroenterology.2023; 29(3): 508. CrossRef

Constructing a prediction model of inflammatory bowel disease recurrence based on factors affecting the quality of life

Maojuan Li, Yan Tao, Yang Sun, Jing Wu, Fengrui Zhang, Yunling Wen, Min Gong, Jingxian Yan, Hao Liang, Xinyu Bai, Junkun Niu, Yinglei Miao

Barriers in inflammatory bowel disease care in Central and Eastern Europe: a region-specific analysis

Michal Prokopič, Georgiana Gilca-Blanariux, Peter Lietava, Anca Trifan, Anna Pietrzak, Agata Ladic, Marko Brinar, Svetlana Turcan, Tamás Molnár, Peter Bánovčin, Milan Lukáš

Therapeutic Advances in Gastroenterology.2023;[Epub] CrossRef

The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care

Holly Mathias, Noelle Rohatinsky, Sanjay K Murthy, Kerri Novak, M Ellen Kuenzig, Geoffrey C Nguyen, Sharyle Fowler, Eric I Benchimol, Stephanie Coward, Gilaad G Kaplan, Joseph W Windsor, Charles N Bernstein, Laura E Targownik, Juan-Nicolás Peña-Sánchez, K

Journal of the Canadian Association of Gastroenterology.2023; 6(Supplement): S111. CrossRef

Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast

Cheng-Jun Li, Yi-Kai Wang, Shun-Ming Zhang, Mu-Dan Ren, Shui-Xiang He

World Journal of Gastroenterology.2023; 29(42): 5764. CrossRef

Oral Administration of Platinum Nanoparticles with SOD/CAT Cascade Catalytic Activity to Alleviate Ulcerative Colitis

Hao Liu, Yujie Zhang, Mingzhen Zhang, Zhaoxiang Yu, Mingxin Zhang

Journal of Functional Biomaterials.2023; 14(11): 548. CrossRef

Global burden of inflammatory bowel disease 1990-2019: A systematic examination of the disease burden and twenty-year forecast

Cheng-Jun Li, Yi-Kai Wang, Shun-Ming Zhang, Mu-Dan Ren, Shui-Xiang He

World Journal of Gastroenterology.2023; 29(42): 5751. CrossRef

IBD barriers across the continents – East Asia

Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng

Therapeutic Advances in Gastroenterology.2023;[Epub] CrossRef

Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment

Irish Journal of Medical Science (1971 -).2022; 191(5): 2105. CrossRef

Ulcerative Colitis and Patient’s Quality of Life, Especially in Early Stage

Quality of life in Malaysian children with inflammatory bowel disease: An understudied population

Gin W Lee, Kee S Chew, Sean Y Wong, Sze Y Chong, Sik Y Ong, Way S Lee

Journal of Paediatrics and Child Health.2022; 58(11): 1972. CrossRef

Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α

The Korean Journal of Internal Medicine.2022; 37(5): 895. CrossRef

Inflammatory bowel disease in Korea: epidemiology and pathophysiology

The Korean Journal of Internal Medicine.2022; 37(5): 885. CrossRef

Correlation of Serum CA242, CA724, and TPA Levels with Clinicopathological Features and Prognosis in Patients with Inflammatory Bowel Disease Complicated with Rectal Cancer